138 related articles for article (PubMed ID: 38420675)
1. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease.
Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675
[TBL] [Abstract][Full Text] [Related]
2. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.
Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA
Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425
[TBL] [Abstract][Full Text] [Related]
3. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
[TBL] [Abstract][Full Text] [Related]
4. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
[TBL] [Abstract][Full Text] [Related]
5. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification.
Ter Braake AD; Eelderink C; Zeper LW; Pasch A; Bakker SJL; de Borst MH; Hoenderop JGJ; de Baaij JHF
Nephrol Dial Transplant; 2020 May; 35(5):765-773. PubMed ID: 31605492
[TBL] [Abstract][Full Text] [Related]
6. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity.
Köppert S; Büscher A; Babler A; Ghallab A; Buhl EM; Latz E; Hengstler JG; Smith ER; Jahnen-Dechent W
Front Immunol; 2018; 9():1991. PubMed ID: 30233585
[No Abstract] [Full Text] [Related]
7. The Role of Secondary Calciprotein Particles in the Mineralisation Paradox of Chronic Kidney Disease.
Cai MMX; Smith ER; Tan SJ; Hewitson TD; Holt SG
Calcif Tissue Int; 2017 Dec; 101(6):570-580. PubMed ID: 28861648
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.
Miura Y; Kurosu H; Kuro-O M
Methods Mol Biol; 2023; 2664():333-341. PubMed ID: 37423998
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate FYB-931 Prevents High Phosphate-Induced Vascular Calcification in Rat Aortic Rings by Altering the Dynamics of the Transformation of Calciprotein Particles.
Kawakami K; Ohya M; Yashiro M; Sonou T; Yamamoto S; Nakashima Y; Yano T; Tanaka Y; Ishida K; Kobashi S; Shigematsu T; Araki SI
Calcif Tissue Int; 2023 Aug; 113(2):216-228. PubMed ID: 37099142
[TBL] [Abstract][Full Text] [Related]
10. Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
Kuro-O M
Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):344-351. PubMed ID: 37074676
[TBL] [Abstract][Full Text] [Related]
11. Live Imaging of Calciprotein Particle Clearance and Receptor Mediated Uptake: Role of Calciprotein Monomers.
Koeppert S; Ghallab A; Peglow S; Winkler CF; Graeber S; Büscher A; Hengstler JG; Jahnen-Dechent W
Front Cell Dev Biol; 2021; 9():633925. PubMed ID: 33996793
[TBL] [Abstract][Full Text] [Related]
12. Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification Potential.
Zeper LW; Smith ER; Ter Braake AD; Tinnemans PT; de Baaij JHF; Hoenderop JGJ
Calcif Tissue Int; 2023 Jan; 112(1):103-117. PubMed ID: 36326853
[TBL] [Abstract][Full Text] [Related]
13. Vascular calcification maladaptively participates in acute phosphate homeostasis.
Turner ME; Rowsell TS; Lansing AP; Jeronimo PS; Lee LH; Svajger BA; Zelt JGE; Forster CM; Petkovich MP; Holden RM; Adams MA
Cardiovasc Res; 2023 May; 119(4):1077-1091. PubMed ID: 36190819
[TBL] [Abstract][Full Text] [Related]
14. Clearance of fetuin-A--containing calciprotein particles is mediated by scavenger receptor-A.
Herrmann M; Schäfer C; Heiss A; Gräber S; Kinkeldey A; Büscher A; Schmitt MM; Bornemann J; Nimmerjahn F; Herrmann M; Helming L; Gordon S; Jahnen-Dechent W
Circ Res; 2012 Aug; 111(5):575-84. PubMed ID: 22753077
[TBL] [Abstract][Full Text] [Related]
15. Acute Tissue Mineral Deposition in Response to a Phosphate Pulse in Experimental CKD.
Zelt JG; Svajger BA; Quinn K; Turner ME; Laverty KJ; Shum B; Holden RM; Adams MA
J Bone Miner Res; 2019 Feb; 34(2):270-281. PubMed ID: 30216554
[TBL] [Abstract][Full Text] [Related]
16. A study on biorelevant calciprotein particles: Effect of stabilizing agents on the formation and crystallization mechanisms.
Gelli R; Pucci V; Ridi F; Baglioni P
J Colloid Interface Sci; 2022 Aug; 620():431-441. PubMed ID: 35439694
[TBL] [Abstract][Full Text] [Related]
17. Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop.
Zeper LW; de Baaij JHF
Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):368-374. PubMed ID: 31045659
[TBL] [Abstract][Full Text] [Related]
18. Very low protein diet enhances inflammation, malnutrition, and vascular calcification in uremic rats.
Yamada S; Tokumoto M; Tatsumoto N; Tsuruya K; Kitazono T; Ooboshi H
Life Sci; 2016 Feb; 146():117-23. PubMed ID: 26764234
[TBL] [Abstract][Full Text] [Related]
19. Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?
Ter Braake AD; Vervloet MG; de Baaij JHF; Hoenderop JGJ
Nephrol Dial Transplant; 2022 Feb; 37(3):421-429. PubMed ID: 33374019
[TBL] [Abstract][Full Text] [Related]
20. Newly Developed Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.
Watanabe K; Fujii H; Goto S; Nakai K; Kono K; Watanabe S; Shinohara M; Nishi S
J Atheroscler Thromb; 2018 Feb; 25(2):170-177. PubMed ID: 28674323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
